Get started
ABBVIEABBVIEABBVIE

ABBVIE

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

1ABBV chart


Full chart

Key facts today


A class action lawsuit claims Cerevel Therapeutics misled investors about AbbVie's acquisition interest, leading to a lower stock price before the merger announcement.
Analyze the impactAnalyze the impact

1ABBV upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪277.23 B‬ EUR
Dividend yield (indicated)
3.66%
Price to earnings Ratio (TTM)
74.0
Basic EPS (TTM)
2.4 EUR
Net income (FY)
‪4.09 B‬ EUR
Revenue (FY)
‪54.42 B‬ EUR
Shares float
‪1.77 B‬
Beta (1Y)
0.13

Employees


Employees (FY)
‪55 K‬
Change (1Y)
‪+5 K‬ +10.00%
Revenue / Employee (1Y)
‪989.41 K‬ EUR
Net income / Employee (1Y)
‪74.43 K‬ EUR

About AbbVie Inc.


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Robert A. Michael
Website
abbvie.com
Headquarters
North Chicago
Founded
2011
FIGI
BBG01K3WR5L6
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1ABBV news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

1ABBV highest yielding bonds


A
ACT3910526
Actavis, Inc. 4.625% 01-OCT-2042
Yield to maturity
7.79%
Maturity date
Oct 1, 2042
A
ACT4218883
Allergan Funding SCS 4.75% 15-MAR-2045
Yield to maturity
7.78%
Maturity date
Mar 15, 2045
A
ACT4176286
Allergan Funding SCS 4.85% 15-JUN-2044
Yield to maturity
7.69%
Maturity date
Jun 15, 2044
A
ACT4218882
Allergan Funding SCS 4.55% 15-MAR-2035
Yield to maturity
6.52%
Maturity date
Mar 15, 2035
ABBV5068387
AbbVie Inc. 4.25% 21-NOV-2049
Yield to maturity
6.37%
Maturity date
Nov 21, 2049
ABBV5068390
AbbVie Inc. 4.75% 15-MAR-2045
Yield to maturity
6.26%
Maturity date
Mar 15, 2045
US287YAW9
ABBVIE 16/46
Yield to maturity
6.22%
Maturity date
May 14, 2046
ABBV4693583
AbbVie Inc. 4.875% 14-NOV-2048
Yield to maturity
6.12%
Maturity date
Nov 14, 2048
4ABB
ABBVIE 15/45
Yield to maturity
6.11%
Maturity date
May 14, 2045
ABBV4036937
AbbVie Inc. 4.4% 06-NOV-2042
Yield to maturity
6.08%
Maturity date
Nov 6, 2042
ABBV5068388
AbbVie Inc. 4.625% 01-OCT-2042
Yield to maturity
6.02%
Maturity date
Oct 1, 2042

See all 1ABBV bonds 

Sparks


Curated watchlists where 1ABBV is featured.

See all sparks 


Check out other big names from the same industry as 1ABBV.

Frequently Asked Questions


The current price of 1ABBV is 153.6 EUR — it has increased by 1.82% in the past 24 hours. Watch ABBVIE stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange ABBVIE stocks are traded under the ticker 1ABBV.
1ABBV stock has fallen by −6.77% compared to the previous week, the month change is a −19.54% fall, over the last year ABBVIE has showed a −0.27% decrease.
We've gathered analysts' opinions on ABBVIE future price: according to them, 1ABBV price has a max estimate of 222.49 EUR and a min estimate of 153.35 EUR. Watch 1ABBV chart and read a more detailed ABBVIE stock forecast: see what analysts think of ABBVIE and suggest that you do with its stocks.
1ABBV reached its all-time high on Mar 4, 2025 with the price of 202.6 EUR, and its all-time low was 127.8 EUR and was reached on Nov 24, 2023. View more price dynamics on 1ABBV chart.
See other stocks reaching their highest and lowest prices.
1ABBV stock is 2.34% volatile and has beta coefficient of 0.13. Track ABBVIE stock price on the chart and check out the list of the most volatile stocks — is ABBVIE there?
Today ABBVIE has the market capitalization of ‪277.23 B‬, it has decreased by −10.01% over the last week.
Yes, you can track ABBVIE financials in yearly and quarterly reports right on TradingView.
ABBVIE is going to release the next earnings report on Apr 25, 2025. Keep track of upcoming events with our Earnings Calendar.
1ABBV earnings for the last quarter are 2.09 EUR per share, whereas the estimation was 2.04 EUR resulting in a 2.12% surprise. The estimated earnings for the next quarter are 2.18 EUR per share. See more details about ABBVIE earnings.
ABBVIE revenue for the last quarter amounts to ‪14.59 B‬ EUR, despite the estimated figure of ‪14.33 B‬ EUR. In the next quarter, revenue is expected to reach ‪11.93 B‬ EUR.
1ABBV net income for the last quarter is ‪−30.91 M‬ EUR, while the quarter before that showed ‪1.39 B‬ EUR of net income which accounts for −102.22% change. Track more ABBVIE financial stats to get the full picture.
Yes, 1ABBV dividends are paid quarterly. The last dividend per share was 1.45 EUR. As of today, Dividend Yield (TTM)% is 3.56%. Tracking ABBVIE dividends might help you take more informed decisions.
ABBVIE dividend yield was 3.54% in 2024, and payout ratio reached 263.15%. The year before the numbers were 3.87% and 220.33% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Apr 16, 2025, the company has ‪55 K‬ employees. See our rating of the largest employees — is ABBVIE on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBVIE EBITDA is ‪19.80 B‬ EUR, and current EBITDA margin is 44.40%. See more stats in ABBVIE financial statements.
Like other stocks, 1ABBV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBVIE stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBVIE technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBVIE stock shows the strong sell signal. See more of ABBVIE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.